BRPI0617511A2 - Conjugado de peptídeo-imunoglobulina - Google Patents

Conjugado de peptídeo-imunoglobulina

Info

Publication number
BRPI0617511A2
BRPI0617511A2 BRPI0617511-2A BRPI0617511A BRPI0617511A2 BR PI0617511 A2 BRPI0617511 A2 BR PI0617511A2 BR PI0617511 A BRPI0617511 A BR PI0617511A BR PI0617511 A2 BRPI0617511 A2 BR PI0617511A2
Authority
BR
Brazil
Prior art keywords
peptide
immunoglobulin conjugate
immunoglobulin
conjugate
Prior art date
Application number
BRPI0617511-2A
Other languages
English (en)
Inventor
Stephan Fischer
Erhard Kopetzki
Suryanarayana Sankuratri
Ralf Schumacher
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35809600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0617511(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0617511A2 publication Critical patent/BRPI0617511A2/pt
Publication of BRPI0617511A8 publication Critical patent/BRPI0617511A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0617511A 2005-10-21 2006-10-19 conjugado de peptídeo-imunoglobulina BRPI0617511A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05023002 2005-10-21
PCT/EP2006/010061 WO2007045463A1 (en) 2005-10-21 2006-10-19 A peptide-immunoglobulin-conjugate

Publications (2)

Publication Number Publication Date
BRPI0617511A2 true BRPI0617511A2 (pt) 2015-07-07
BRPI0617511A8 BRPI0617511A8 (pt) 2018-04-24

Family

ID=35809600

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0617511A BRPI0617511A8 (pt) 2005-10-21 2006-10-19 conjugado de peptídeo-imunoglobulina

Country Status (13)

Country Link
US (1) US20070148180A1 (pt)
EP (1) EP1940882A1 (pt)
JP (1) JP2009512655A (pt)
KR (1) KR20080070014A (pt)
CN (1) CN101291956A (pt)
AR (1) AR056137A1 (pt)
AU (1) AU2006303438A1 (pt)
BR (1) BRPI0617511A8 (pt)
CA (1) CA2625332A1 (pt)
IL (1) IL190552A0 (pt)
NO (1) NO20081704L (pt)
TW (1) TW200722436A (pt)
WO (1) WO2007045463A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
US7825093B2 (en) 2006-10-25 2010-11-02 Amgen Inc. Methods of using OSK1 peptide analogs
CA2840407A1 (en) 2007-05-22 2008-12-18 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
ES2695999T3 (es) 2007-10-12 2019-01-11 Hoffmann La Roche Expresión de proteínas a partir de múltiples ácidos nucleicos
US20120121591A1 (en) * 2009-03-20 2012-05-17 Amgen Inc. SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
CA2781532A1 (en) 2009-11-20 2011-05-26 Amgen Inc. Anti-orai1 antigen binding protein that binds the second extracellular loop of orai1
EA201370030A1 (ru) 2010-08-10 2013-06-28 Амген Инк. Бифункциональный количественный анализ in vitro связывания мишени для обнаружения нейтрализующих антител к антителам-мишеням
US8993727B2 (en) * 2010-09-22 2015-03-31 Amgen Inc. Carrier immunoglobulins and uses thereof
EP2665822A1 (en) 2011-01-18 2013-11-27 Amgen Inc. Nav1.7 knockout mice and uses thereof
JP2015505843A (ja) * 2011-12-15 2015-02-26 ザ・ロイヤル・インスティテューション・フォア・ザ・アドバンスメント・オブ・ラーニング／マクギル・ユニヴァーシティ 可溶性ＩＧＦレセプターＦｃ融合タンパク質およびその使用
AU2013222188A1 (en) 2012-02-22 2014-09-11 Amgen Inc. Autologous mammalian models derived from induced pluripotent stem cells and related methods
MX2017004769A (es) 2014-10-15 2017-10-16 Amgen Inc Elementos promotores y reguladores para mejorar la expresion de genes heterologos en celulas hospederas.
US20190382462A1 (en) 2017-01-13 2019-12-19 Pietro P. Sanna Methods and compositions for treating hpa hyperactivity
US20200283492A1 (en) * 2017-09-29 2020-09-10 Hanmi Pharm Co., Ltd. Long acting protein complex having an enhanced efficiency

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567584A (en) * 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
WO1993024135A1 (en) * 1992-05-26 1993-12-09 Immunex Corporation Novel cytokine that binds cd30
US6620413B1 (en) * 1995-12-27 2003-09-16 Genentech, Inc. OB protein-polymer chimeras
JP4124486B2 (ja) * 1996-05-22 2008-07-23 ビベンティア バイオテック インコーポレイテッド ガン細胞を特異的に検出する抗原結合フラグメント、このフラグメントをコードするヌクレオチド、ならびにガンの予防および検出のためのその使用
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
EP1292621B1 (en) * 2000-06-05 2006-09-20 University of Tennessee Corporation Compositions for treating autoimmune disease
US20030077826A1 (en) * 2001-02-02 2003-04-24 Lena Edelman Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
CN1901931A (zh) * 2004-01-07 2007-01-24 特里梅里斯公司 HIV gp41 HR2－来源的合成肽,及其在抑制人类免疫缺陷性病毒传递的治疗中的用途

Also Published As

Publication number Publication date
EP1940882A1 (en) 2008-07-09
TW200722436A (en) 2007-06-16
AU2006303438A1 (en) 2007-04-26
CN101291956A (zh) 2008-10-22
NO20081704L (no) 2008-06-05
IL190552A0 (en) 2008-11-03
JP2009512655A (ja) 2009-03-26
KR20080070014A (ko) 2008-07-29
CA2625332A1 (en) 2007-04-26
US20070148180A1 (en) 2007-06-28
BRPI0617511A8 (pt) 2018-04-24
WO2007045463A1 (en) 2007-04-26
AR056137A1 (es) 2007-09-19

Similar Documents

Publication Publication Date Title
BRPI0617511A8 (pt) conjugado de peptídeo-imunoglobulina
DK1928882T3 (da) (s)-n-methylnaltrexon
ATE408603T1 (de) Pyrazolylcarboxanilide
CR9974A (es) Gavión
DE502006003394D1 (de) Lehnenklappung
DE502006008475D1 (de) Wasserpumpenflügelrad
DK1943406T3 (da) Byggeelement
DE502006005667D1 (de) Gelenklager
ATE549324T1 (de) Tetrahydrobenzoxazine
DE502006006857D1 (de) Wingungserregern
DE112006002964A5 (de) Zweirichtungsreflektanzverteilungsmessgerät
DE502005005839D1 (de) Feldgeerät
DE502006001397D1 (de) Lagerbuchse
DE502006006589D1 (de) Teils
ATE485368T1 (de) Hiv - impfung
DE502006004302D1 (de) Verschlusskappe
DE502006003147D1 (de) Verbundgußplatte
DE502006001004D1 (de) Hydrolager
DE102005052834B8 (de) Punktschweißklebverbindung
DE502006003210D1 (de) Nohydrogenpolysiloxanen
AT501523A3 (de) Estrich
DK1960510T3 (da) Ammoniakspecifik 5'-xmp-aminasemutant
DE602006007836D1 (de) Kontrastmittel
DE102006033170A8 (de) Einfassnähmaschine
DE502006006199D1 (de) Rzuständen

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: APRESENTE NOVAS VIAS DE DESENHOS, SEM CORES, CONFORME DETERMINA O ITEM 15.1.4.1 (B) DO AN NO 127/1997.

B12C Appeal against dismissal [chapter 12.3 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]